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Abstract
BACKGROUND: Morbidity rate of circulatory system diseases (CSD) in Kazakhstan continues to grow and the 
metabolic syndrome (MetS) contributes significantly to cardiovascular risk development. It was known that MetS 
altered autonomic nervous system (ANS) by decreasing parasympathetic activity and global heart rate variability 
(HRV), at the same time, the decrease in sympathetic modulation is unclear. Studies investigated associations 
between anxiety and MetS disorders are rather controversial. Research findings of the MetS influence on health-
related quality of life (HRQoL) were also contradictory. The above-mentioned justifies the necessity of research to 
clarify and deepen the MetS etiology and pathogenesis, as well as to improve its diagnostics efficiency and treatment. 
AIM: The research goals were to study psychophysiological status and HRQoL in individuals with MetS living in 
Central Kazakhstan.
MATERIALS AND METHODS: Three hundred MetS patients were examined in Karaganda city clinical hospital. 
Statistical methods and spectral analysis of HRV, simple visual-motor reaction (SVMR), the Spielberger State-Trait 
Anxiety Inventory, and the Lüscher color test were used. SF-36 questionnaire was used for HRQoL assessment.
RESULTS: General decrease in the activity of both sympathetic and parasympathetic branches of ANS was 
observed in MetS patients. More than half of the examined MetS patients have had a high level of trait anxiety. Most 
MetS patients have had a low level of the central nervous system (CNS) functional activity. MetS patients are active 
both in physical and social spheres. Bodily pain syndrome greatly influences MetS patients’ life quality. The patients 
evaluate their health level as being low.
CONCLUSION: Individuals with MetS living in Central Kazakhstan had decreased activity of ANS, prevalence of 
inhibition processes in CNS, high level of trait anxiety, and bodily pain syndrome affecting life quality.
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Introduction
Morbidity rate of circulatory system diseases 
(CSD) in Kazakhstan continues to grow and mortality 
rate of CSD continues to be the main cause of 
general population mortality among all existing 
disease classes [1], [2]. In industrial regions of Central 
Kazakhstan, the development of CSD, among which 
75% are arterial hypertension, can be influenced by 
environmental factors [3]. The metabolic syndrome 
(MetS) contributes significantly to cardiovascular risk 
development, with abdominal obesity and hypertension 
being the leading components [4].
The above-mentioned justifies the necessity 
of researches to clarify and deepen the etiology and 
pathogenesis comprehension, as well as to improve 
diagnostics efficiency and treatment of ecologically 
caused health issues.
There is strong evidence that obesity leads to 
an increased sympathetic modulation and a decreased 
vagal tone, which in turn leads to the lack of autonomic 
control, characterized by heart rate variability (HRV) 
reduction. Increased muscle sympathetic nerve 
activity, changes in renin-angiotensin-aldosterone 
system and plasma catecholamines are important 
characteristics of obese individuals [5], [6], [7]. All these 
factors further contribute to increased blood pressure 
(BP)  8], [9], [10].
Recently, HRV has become an important 
instrument for autonomic modulation evaluation. In 
their study, Koskien et al. [11] showed that overall 
HRV is significantly reduced in adults with MetS. 
The association of individual components of MetS 
with HRV differed according to gender. They found 
that women with MetS had lower vagal activity and 
that there was a possible increase in sympathetic 
predominance.
Duanping et al. examined the relationship 
between cardiac autonomic activity level and MetS 
disorders [12]. In their research, high-frequency (HF) 
and low-frequency (LF) spectral powers, LF to HF 
ratio, and the standard deviation (SD) of all normal 
R-R intervals were used as the conventional indices 
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of HRV for cardiac autonomic activity measurement. 
The MetS disorders included hypertension, type 2 
diabetes, and dyslipidemia. Findings suggest that 
MetS disorders adversely affect cardiac autonomic 
control and that reduced cardiac autonomic control 
may contribute to the increased risk of subsequent 
cardiovascular events in individuals with MetS 
disorders.
Stuckey et al. [7] conducted a systematic 
review on 14 studies published primary researches, 
which examined associations between HRV, MetS, 
and its individual risk factors. After the systematic 
review, it was concluded that the HRV was generally 
reduced in women with MetS, while results in men 
were inconsistent. Time and frequency domain of HRV 
parameters were associated with individual MetS risk 
factors, though gender differences exist.
It can be concluded that MetS altered autonomic 
nervous system (ANS) by decreasing parasympathetic 
activity and global HRV, at the same time, the decrease 
in sympathetic modulation is unclear.
According to a meta-analysis by Booth 
et al. [13], anxiety among the population remains 
and has a tendency to spread and grow. Several 
studies investigated associations between anxiety 
and MetS disorders; however, findings in this field 
are rather controversial. Carrol et al. [14] report on 
the positive relationship between generalized anxiety 
disorder (GAD) and MetS. Similar findings presented 
by Luppino et al. [15], Ribeiro et al. [16], and Kahl 
et al. [17] point to the association between anxiety/
depression and MetS.
In contrast, Norwegian researchers [18] found 
no connections between anxiety/depression and MetS. 
Others reported on exclusively finding depression 
related to MetS [19], [20].
A number of authors researched MetS influence 
on health-related quality of life (HRQoL); however, 
results were contradictory. Iranian researchers [21] 
showed that MetS was connected to women’s low 
scores in physical functioning (PF), bodily pain, and 
social functioning domains. Dutch scientists [22] found 
that both obese men and women with MetS had a higher 
probability of poor scores in the domains of general 
health, vitality, social functioning, and role limitations 
due to emotional problems even after adjusting for 
body mass index (BMI). According to an earlier study by 
American scientists [23], this association was eliminated 
by controlling for BMI. Moreover, they showed that MetS 
was not associated with lower mental quality of life. On 
the contrary, Greek researchers [24] found that MetS 
patients showed significantly lower physical and mental 
components summary scores than patients without the 
syndrome.
The research goals were to study 
psychophysiological status and life quality in individuals 
with MetS living in Central Kazakhstan.
Materials and Methods
In Kazakhstan, the MetS is prevalent in 25% of 
the adult population [25]. Based on type I error (α=5%), 
the required sample size (n) should be equal: 
−
= =
2
2
(100 ) 300
5
t p pn
The study was performed at Karaganda city 
clinical hospital. Three hundred MetS patients were 
examined: 192 women and 108 men, aged 18–65 years. 
According to the authors of diagnostics and management 
of MetS in the Republic of Kazakhstan, MetS diagnostics 
criteria should be the same as the European Standards. 
Studies in Kazakhstan show that the waist circumference 
(WC) measurement reflects mostly the degree of insulin 
resistance in patients [25], [26]. By the International 
Diabetes Federation (IDF) criteria [27] and experts of 
the Russian Scientific Society of Cardiology on the 
diagnosis and treatment of MetS [4], MetS was defined 
as the combination of WC ≥ 80 cm in women and ≥94 cm 
in men with two and more risk factors (triglycerides ≥1.7 
mmol/l, high-density lipoprotein (HDL) cholesterol <1.2 
in women, HDL cholesterol < 1.0 mmol/l in men, fasting 
plasma glucose ≥ 5.6 mmol/l, BP ≥ 130/85 mm Hg, 
or taking antihypertensive medication). Patients with 
hyperglycemia had prediabetes and their blood glucose 
is higher than usual but not so high as to constitute 
diabetes. Cardiac arrhythmia and cognitive disorder 
were excluding criteria.
Ethics Committee approved the study. The 
patients gave informed consent to participate in the 
research.
Data collection
WC, triglycerides, HDL cholesterol, fasting 
plasma glucose, and BP measurements were 
observed. Arterial hypertension (AH) diagnostics were 
done according to the clinical recommendations [28] 
and the clinical protocol on AH of Healthcare and Social 
Development of the Republic of Kazakhstan [29].
Assessment of autonomic regulation of the 
heart was performed by analyzing HRV using statistical 
methods and spectral analysis [30].
Central nervous system (CNS) activation 
level was assessed by simple visual-motor reaction 
(SVMR) [31].
To determine patients’ anxiety level, the 
Spielberger State-Trait Anxiety Inventory was 
employed [32].
The patients’ psychophysiological state was 
evaluated by the Lüscher color test [33].
SF-36 questionnaire was used for HRQoL 
assessment [34].
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Statistical analysis
Quantitative data, in the case of the normal 
distribution, were presented as mean values (M) 
and standard errors of the mean (m). In the case of 
non-normal distribution, data were presented in the 
form of median (Me), lower (Q25), and upper (Q75) 
quartiles. Qualitative data were presented in the form 
of a percentage of (p) with a 95% confidence interval 
(CI). Relationships were assessed by Spearman’s 
rank correlation coefficient. R software was used for 
calculations.
Results
The clinical study involved 300 patients 
with MetS, mean age 52.29±8.76 years. Females 
predominated among the examined patients 
(63.93±6.15%). Age and gender are presented in 
Table 1.
Metabolic disorders were most frequent among 
40–49 and 50–59 age groups for total subjects (26.33%; 
CI [21.44–31,70]% and 41.00%; CI [35.38–46.80]%, 
respectively).
The main components of MetS were obesity 
(211 patients [70.33%; CI {64.81–75.45}%]) and 
hypertension (250 patients [83.33% CI {78.62-87.37}%]) 
with predominating Grade 1 hypertension: (140–159) 
mmHg systolic and/or (90–99) mmHg diastolic BP 
(66.67%; CI [61.02–71.98]%). Dyslipidemia was 
diagnosed in 46% of cases (CI [40.26-51.82]%) and 
dysglycemia in 27% (CI [22.99-33.45]%).
When describing the condition of MetS patients, 
it is necessary to evaluate not only carbohydrate and 
lipid metabolism indicators but also neurohumoral 
system parameters. To assess the neurohumoral 
system, HRV analysis was used. This analysis provides 
information about heart rhythm autonomic regulation 
and overall status of the ANS [35], [36].
Table 2 data are the integral indicators of HRV 
in general, reflecting a balance between sympathetic 
and parasympathetic nervous systems influences.
Presented HRV statistical indicators are 
generally significantly lower than normative figures. In 
the study group, SDNN, RMSSD, pNN50% decreased 
2, 3, and 4 times, respectively. The average pulse rate 
was around 80 beats/min. Aforementioned indicators 
give evidence for autonomic balance shift toward 
sympathetic nervous system predominance and 
significant strain in the heart rhythm regulation system.
Spectral analysis components (Table 3) 
characterize HRV periodic components and can be used 
for a separate description of both branches of the ANS.
There is a significant decrease in total 
power (TP) of the cardiointervalogram’s spectrum 
and individual spectral components in the study 
group, which is evidence of the significant rhythm 
stabilization. HF component of the spectrum is weakly 
expressed both in absolute terms HF = (301.83 ± 
98.55) ms2 and percentage HF = (17.56 ± 3.31)% to 
TP. These fluctuations reflect vagal influences on 
cardiac rhythm and point to the decreasing activity of 
the parasympathetic branch in the study group. Low 
frequency (LF) = (899.19 ± 398.14) ms2 for the study 
group, (1170 ± 416) ms2 for healthy individuals, and 
very low-frequency components VLF = (330.68 ± 
107.68) ms2 against the normal (1267 ± 400) ms2 are 
weakly expressed. Therefore, sympathetic branch 
activity is also significantly lower in comparison to 
healthy individuals. Nevertheless, there is a balance shift 
toward sympathetic branch since LF/HF = 3.77± 0.92.
Thus, no significant peaks were observed, 
while evaluating the percentage contribution of 
each spectral component to the total spectral power. 
LF = 36.12% waves prevail slightly.
The studied sample contained the least number 
of patients with low trait anxiety (11.11%) (Table 4).
The number of patients with moderate trait anxiety 
level was two times greater – 27.78%. More than half of 
the patients (61.11%) had a high level of trait anxiety.
Table 1: Distribution of patients by age and gender
Age group 
years
Total Male Female
n % 95% CI n % 95% CI n % 95% CI
20-29 15 5.00 2.83-8.11 5 4.63 1.52-10.47 10 5.21 2.53-9.37
30-39 49 16.33 12.33-21.01 15 13.89 7.99-21.87 34 17.71 12.59-23.86
40-49 79 26.33 21.44-31.70 39 36.11 27.09-45.92 40 20.83 15.32-27.27
50-59 123 41.00 35.38-46.80 29 26.85 18.78-36.24 94 48.96 41.69-56.26
60-65 34 11.33 7.98-15.48 20 18.52 11.69-27.14 14 7.29 4.04-11.93
Total 300 100 108 192
Table 2: Statistical HRV indicators (M ± m)
Indicator Study group Normal
HR beats/min 79.31 ± 3.27 60–80
RRNN (ms) 774.14 ± 30.75 800 ± 56
SDNN (ms) 29.74 ± 4.67 63 ± 35
RMSSD (ms) 20.42 ± 3.46 64 ± 6
pNN50% 5.09 ± 2.39 21.1 ± 5.1
HR beats/min is the heart rate, RRNN (ms) is the mean duration of all normal R-R intervals, RMSSD (ms) is 
the root mean square of the successive differences of all R-R intervals, SDNN (ms) is the standard deviation 
of R-R intervals, pNN50% is the number of adjacent intervals differing more than 50 ms expressed as a 
percentage of all the intervals in the collecting period.
Table 3: Spectral HRV indicators (M ± m)
Indicator Study group Normal
TP (ms2) 1855.06 ± 647.4 3105 ± 1018
HF (ms2) 301.83 ± 98.55 668 ± 203
LF (ms2) 899.19 ± 398.14 1170 ± 416
VLF (ms2) 330.68 ± 107.68 1267 ± 400
HF% 17.56 ± 3.31 15-45
LF% 36.12 ± 4.34 20-50
VLF% 21.82 ± 2.57 20-50
LF/HF 3.77 ± 0.92 1.5-2.0
TP is the total power, HF is the high frequency, LF is the low frequency, VLF is the very low frequency. They are 
determined when heart rate variability is plotted as a frequency at which the length of the R-R intervals changes.
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The greatest number of patients (85.71%) was 
characterized by a low level of state anxiety, lack of 
tension, and nervousness at the time of the study. Only 
7.14% of patients with high-level state anxiety were 
identified during the psychophysiological examination.
The study of preferred colors’ positional 
frequency distribution in MetS patients (Table 5) showed 
the presence of color selecting specialties in the group.
In 37.5% of cases, red color did not occupy 
the first three positions, i.e., was rejected. There was 
a shift of yellow color to the eighth position of the color 
selection. More than half of the patients (56.3%) chose 
a green color for the first and second positions. Brown 
color appears on the second position in 31.25% of 
cases.
About 80% of the examined patients were 
characterized by a low level of CNS activation (Table 6).
Time reaction Me in this group was 321 
msec (Q25=313 msec; Q75=337 msec). The standard 
deviation Me of the time reaction was 99 msec (Q25=80 
msec; Q75=113 msec). Increases of the time reaction 
to visual triggers above 270 msec and its standard 
deviation values above 80 msec show inhibitory 
processes prevalence and reduced level of CNS 
functionality.
The remaining part of the patients (20%) 
showed average level of CNS activation and stable 
condition of regulatory mechanisms. Time reaction Me 
in this group was 287 msec (Q25=278 msec; Q75=290 
msec). Time reaction standard deviation was 66 msec 
(Q25=56 msec; Q75=67 msec). No patients in the studied 
sample had a high level of CNS activation. Half of the 
examined patients showed moderate resistance of 
visual-motor reaction.
Table 4: Anxiety levels frequency distribution among MetS 
patients
Indicator n % 95% CI
Level of trait anxiety No or low 8 11.11 5.07–21.25
Moderate 19 27.78 16.73–37.56
High 43 61.11 49.03–72.83
Level of state anxiety No or low 60 85.71 75.29–92.93
Moderate 5 7.14 2.36–15.89
High 5 7.14 2.36–15.89
No or low anxiety level: STAI scores (20–37), moderate anxiety level: STAI scores (38–44), high anxiety 
level: STAI scores (45–80).
The statistical significant correlations between 
functional level of CNS activation and level of trait 
anxiety (rs = –0.516, p = 0.002), and position of the 
yellow color (rs = 0.581, p = 0.015) were identified in the 
study sample.
PF in the study group was at a high level, Me 
of PF was 80 points, according to Table 7. Patients’ 
physical condition did not prevent role-PF (RP) 
achievement – Me of RP was equal to 100 points.
Life quality is significantly affected by pain. 
According to the questionnaire, half of the patients had 
< 60 points on BP scale, while interquartile range (ΔQ) 
was from 41 to 100 points. This corresponds to patients’ 
low GH level assessment. Me of GH was 52 points and 
ΔQ was from 45 to 62 points.
During mental health evaluation, it was found 
that the patients had a high level of fatigue and low 
vitality. Me of values on VT scale was 60 points.
Psychological health was average overall. 
Me of small dispersion MH scale was 68 points (ΔQ 
was from 52 to 80 points). At the same time, emotional 
condition was satisfactory and did not have a significant 
impact on the quality of daily activity, Me of RE was 100 
points. High social activity (communication, spending 
time with friends, family, neighbors, and team) was 
observed to be preserved in the patients, which is 
traditional for Kazakhstan mentality (Me of SF was 87 
points).
Discussion
Metabolic disorders were most frequent among 
40–49 and 50–59 age groups. The main components of 
MetS were obesity and hypertension with predominating 
Grade 1 hypertension.
Table 6: Indicators of simple visual-motor reaction
Indicator n % 95% CI
Functional level of CNS activation low 56 80.00 68.73–88.61
moderate 14 20.00 11.39–31.27
high - - -
Reaction resistance low 13 18.57 10.28–29.66
moderate 35 50.00 37.80–62.20
high 22 31.43 20.85–43.63
Heart rate is intricately regulated by complex 
interactions of multiple mechanisms, including 
sympathetic and parasympathetic nervous system, 
as well as hormonal homeostasis. HRV, which means 
variation of beat-to-beat interval, is a noninvasive way 
to evaluate cardiac ANS functions [37]. Given the 
potential mechanism underlying the development of 
MetS and its major cardiovascular complications, HRV 
is well recognized for its predictive power.
Table 5: Preferred colors’ positional frequency distribution in 
MetS patients
Color Position
1-st (%) 2-nd (%) 3-rd (%) 4-th (%) 5-th (%) 6-th (%) 7-th (%) 8-th (%)
1. Blue 6.25 6.25 6.25 18.75 50.00 12.50 0.00 0.00
2. Green 31.25 25.00 31.25 12.50 0.00 0.00 0.00 0.00
3. Red 31.25 18.75 12.50 6.25 6.25 12.50 6.25 6.25
4. Yellow 18.75 0.00 25.00 25.00 0.00 12.50 0.00 18.75
5. Violet 12.50 18.75 6.25 12.50 6.25 31.25 12.50 0.00
6. Brown 0.00 31.25 0.00 0.00 0.00 25.00 37.50 6.25
7. Black 0.00 0.00 6.25 6.25 12.50 0.00 18.75 56.25
0. Gray 0.00 0.00 12.50 18.75 25.00 6.25 25.00 12.50
Table 7: Life quality domains in MetS patients according to 
SF-36 questionnaire
Domains Me Q25 Q75
Physical health Physical functioning 80.0 60.00 95.0
Role-physical functioning 100.0 75.00 100.0
Bodily pain 62.0 41.00 100.0
General health 52.0 45.00 62.0
Mental health Vitality 60.0 47.50 75.0
Role-emotional 100.0 66.00 100.0
Mental health 68.0 52.00 80.0
Social functioning 87.0 62.00 100.0
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In the present study, several conventional 
parameters (SDNN, RMSSD, pNN50%) were able to 
distinguish MetS.
The clustering of various cardiovascular risks 
referred to as the MetS have led to the fact that patients 
with cardiovascular diseases often have one or more 
MetS components or undetected diabetes mellitus [38]. 
Cardiac dynamic alterations are associated with 
increased cardiovascular risk profile such as insulin-
resistance, endothelial dysfunction, arterial stiffening, 
cardiac hypertrophy, and sympathetic activation [39]. 
Results from previous studies have shown that MetS 
factors by themselves, or in any combination, portend 
cardiovascular disease, and many other adverse 
outcomes [40].
Stuckey et al. [7] reviewed 14 investigations 
evaluating the relationship between HRV and MetS and 
found that high fasting plasma glucose (FPG) might 
be associated with decreased LF and HF, increased 
LF/HF ratio, along with neural effects on TP and VLF. 
The impact of FPG could be roughly interpreted as 
decreasing the parasympathetic tone and the mixture 
of both sympathetic and parasympathetic tone but not 
yet reaching the decrease of total autonomic tone. 
However, the results were not totally the same with our 
findings in which both sympathetic and parasympathetic 
tone, as well as total autonomic nervous tone, were 
decreased in MetS patients by means of significantly 
decreased values of VLF, LF, HF, and TP. It is possible 
that the humoral-metabolic component acquires all 
the more increasing role in heart rhythm regulation. 
The identified set of HRV indicators allows diagnosing 
neurocardiopathy due to systemic and local 
neurohormonal disorders.
It is a known fact that high trait anxiety 
correlates directly with neurotic conflict, emotional and 
neurotic breakdown, and psychosomatic diseases [41]. 
Moreover, at the high level of trait anxiety, clinical 
course of cardiovascular disease runs worse than at 
the average and low levels [42].
Several prior studies of MetS have documented 
that anxiety had a significant positive association 
with MetS [43], [44]. This study showed that high trait 
anxiety level but not state anxiety level accompanied 
MetS, as already reported earlier by Lemche et al. [45]. 
More than half of the patients had a high level of trait 
anxiety. Trait anxiety describes a stable tendency to 
perceive a large range of situations as a threat and to 
react with a state of anxiety. However, initially, anxiety is 
not a negative trait. A certain level of anxiety is a natural 
and necessary feature of active personality. In addition, 
trait anxiety characterizes vulnerability (or resilience) 
to influence of various stressors in general. Anxiety as 
a state (state anxiety) includes components such as 
subjective feelings of tension, anxiety, agitation, fear, 
and ANS activation. State anxiety is characterized by 
stress level at the time of the study. State anxiety of 
the same individual can vary at different times [46]. The 
greatest number of patients was characterized by a low 
level of state anxiety, lack of tension, and nervousness 
at the time of the study. However, a small number of 
patients with high-level state anxiety were revealed in 
this study. These patients were in a state characterized 
by subjective emotions, stress, anxiety, concern, and 
nervousness. It is possible that this state appeared as 
an emotional response to the situation caused by the 
medical check-up.
According to M. Lüscher’s data, color choices 
“34215607” or “43251607” are close to average standard 
values and reflect an optimistic and cheerful personality 
position, absence of tension, anxiety, and stress [47]. 
The first position of the color selection corresponds to 
lead personal tendencies and predominant aspects of 
the motivational sphere. More than half of the patients 
chose a green color for the first and second positions. 
It follows from these color choices that rigidly introvert 
tendencies with the need to defend their own position, 
defensiveness, and aggressiveness of defensive 
nature were more common in the study group. Red 
color shift exposes emotional-vegetative tension, to 
the point of physiological and nervous exhaustion in 
the study sample. The choice of the yellow color as 
the last indicates anxiety and depression in addition 
to that. The choice of brown color, as the preferred 
color, characterizes the high level of anxiety and points 
to the need of anxiety reduction and the pursuit of 
psychological and physical comfort. In addition, brown 
on the second position reflects an anxiety problem, 
which has a vital (somatic) overtone and is associated 
with malaise, fatigue, and overexertion.
Examination of SVMR allowed revealing 
patients with persistent predominance of inhibition 
processes and a reduced level of CNS functional 
possibilities. Simultaneously the higher the level of trait 
anxiety and depression, the less functional level of CNS 
activation was in MetS patients.
MetS patients are active both in physical 
and social spheres. Their aspirations were explicitly 
expressed as communication, interaction with others, 
and social functions fulfillment. Bodily pain syndrome 
greatly influences MetS patients’ life quality. The patients 
evaluate their health level as being low. A significant 
number of patients have noted a decline of vital energy. 
Emotional state of the patients did not affect the quality 
of their daily activities.
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